Taiwan · Delayed Price · Currency is TWD Beiley Biofund Statistics
Total Valuation
Beiley Biofund has a market cap or net worth of TWD 5.67 billion. The enterprise value is 4.88 billion.
| Market Cap | 5.67B |
| Enterprise Value | 4.88B |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | Sep 3, 2026 |
Share Statistics
Beiley Biofund has 212.47 million shares outstanding. The number of shares has increased by 0.03% in one year.
| Current Share Class | 212.47M |
| Shares Outstanding | 212.47M |
| Shares Change (YoY) | +0.03% |
| Shares Change (QoQ) | -0.10% |
| Owned by Insiders (%) | 2.93% |
| Owned by Institutions (%) | 4.91% |
| Float | 120.99M |
Valuation Ratios
The trailing PE ratio is 7.16.
| PE Ratio | 7.16 |
| Forward PE | n/a |
| PS Ratio | 6.27 |
| PB Ratio | 2.07 |
| P/TBV Ratio | 2.07 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 6.14 |
| EV / Sales | 5.39 |
| EV / EBITDA | 5.76 |
| EV / EBIT | 5.77 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.18, with a Debt / Equity ratio of 0.00.
| Current Ratio | 2.18 |
| Quick Ratio | 2.18 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | 0.01 |
| Debt / FCF | -0.04 |
| Interest Coverage | 9,717.32 |
Financial Efficiency
Return on equity (ROE) is 31.91% and return on invested capital (ROIC) is 39.56%.
| Return on Equity (ROE) | 31.91% |
| Return on Assets (ROA) | 19.49% |
| Return on Invested Capital (ROIC) | 39.56% |
| Return on Capital Employed (ROCE) | 30.80% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.33 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Beiley Biofund has paid 77.61 million in taxes.
| Income Tax | 77.61M |
| Effective Tax Rate | 8.91% |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 23.76 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 59.76 |
| Average Volume (20 Days) | 673,625 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Beiley Biofund had revenue of TWD 905.49 million and earned 793.94 million in profits. Earnings per share was 3.73.
| Revenue | 905.49M |
| Gross Profit | 905.49M |
| Operating Income | 845.41M |
| Pretax Income | 871.55M |
| Net Income | 793.94M |
| EBITDA | 846.38M |
| EBIT | 845.41M |
| Earnings Per Share (EPS) | 3.73 |
Balance Sheet
The company has 799.33 million in cash and 4.96 million in debt, with a net cash position of 794.36 million or 3.74 per share.
| Cash & Cash Equivalents | 799.33M |
| Total Debt | 4.96M |
| Net Cash | 794.36M |
| Net Cash Per Share | 3.74 |
| Equity (Book Value) | 2.74B |
| Book Value Per Share | 12.90 |
| Working Capital | 435.18M |
Cash Flow
In the last 12 months, operating cash flow was -138.09 million and capital expenditures -363,000, giving a free cash flow of -138.46 million.
| Operating Cash Flow | -138.09M |
| Capital Expenditures | -363,000 |
| Depreciation & Amortization | 973,000 |
| Net Borrowing | -1.03M |
| Free Cash Flow | -138.46M |
| FCF Per Share | -0.65 |
Margins
Gross margin is 100.00%, with operating and profit margins of 93.37% and 87.68%.
| Gross Margin | 100.00% |
| Operating Margin | 93.37% |
| Pretax Margin | 96.25% |
| Profit Margin | 87.68% |
| EBITDA Margin | 93.47% |
| EBIT Margin | 93.36% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 1.35, which amounts to a dividend yield of 5.07%.
| Dividend Per Share | 1.35 |
| Dividend Yield | 5.07% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 3.88% |
| FCF Payout Ratio | n/a |
| Buyback Yield | -0.03% |
| Shareholder Yield | 5.03% |
| Earnings Yield | 14.00% |
| FCF Yield | -2.44% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on September 3, 2026. It was a forward split with a ratio of 1.035.
| Last Split Date | Sep 3, 2026 |
| Split Type | Forward |
| Split Ratio | 1.035 |
Scores
Beiley Biofund has an Altman Z-Score of 9.38 and a Piotroski F-Score of 2.
| Altman Z-Score | 9.38 |
| Piotroski F-Score | 2 |